TrialHPB : the official journal of the International Hepato Pancreato Biliary Association2013

Reduction in circulating pro-angiogenic and pro-inflammatory factors is related to improved outcomes in patients with advanced pancreatic cancer treated with gemcitabine and intravenous omega-3 fish oil.

Ali Arshad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.